Document Type
Article
Publication Date
11-26-2021
Identifier
DOI: 10.15585/mmwr.mm7047a1; PMCID: PMC8612514
Abstract
Enterovirus D68 (EV-D68) is associated with a broad spectrum of illnesses, including mild to severe acute respiratory illness (ARI) and acute flaccid myelitis (AFM). Enteroviruses, including EV-D68, are typically detected in the United States during late summer through fall, with year-to-year fluctuations. Before 2014, EV-D68 was infrequently reported to CDC (1). However, numbers of EV-D68 detection have increased in recent years, with a biennial pattern observed during 2014-2018 in the United States, after the expansion of surveillance and wider availability of molecular testing. In 2014, a national outbreak of EV-D68 was detected (2). EV-D68 was also reported in 2016 via local (3) and passive national (4) surveillance. EV-D68 detections were limited in 2017, but substantial circulation was observed in 2018 (5). To assess recent levels of circulation, EV-D68 detections in respiratory specimens collected from patients aged <18 years* with ARI evaluated in emergency departments (EDs) or admitted to one of seven U.S. medical centers† within the New Vaccine Surveillance Network (NVSN) were summarized. This report provides a provisional description of EV-D68 detections during July-November in 2018, 2019 and 2020, and describes the demographic and clinical characteristics of these patients. In 2018, a total of 382 EV-D68 detections in respiratory specimens obtained from patients aged <18 years with ARI were reported by NVSN; the number decreased to six detections in 2019 and 30 in 2020. Among patients aged <18 years with EV-D68 in 2020, 22 (73%) were non-Hispanic Black (Black) persons. EV-D68 detections in 2020 were lower than anticipated based on the biennial circulation pattern observed since 2014. The circulation of EV-D68 in 2020 might have been limited by widespread COVID-19 mitigation measures; how these changes in behavior might influence the timing and levels of circulation in future years is unknown. Ongoing monitoring of EV-D68 detections is warranted for preparedness for EV-D68-associated ARI and AFM.
Journal Title
MMWR. Morbidity and mortality weekly report
Volume
70
Issue
47
First Page
1623
Last Page
1628
MeSH Keywords
Adolescent; Child; Child, Preschool; Disease Outbreaks; Enterovirus D, Human; Enterovirus Infections; Female; Humans; Infant; Male; Population Surveillance; Respiratory Tract Infections; United States
Keywords
Disease Outbreaks; Enterovirus D, Human; Enterovirus Infections; Population Surveillance; Respiratory Tract Infections; United States
Recommended Citation
Shah MM, Perez A, Lively JY, et al. Enterovirus D68-Associated Acute Respiratory Illness ─ New Vaccine Surveillance Network, United States, July–November 2018–2020. MMWR Morb Mortal Wkly Rep 2021;70:1623–1628. DOI: http://dx.doi.org/10.15585/mmwr.mm7047a1
Comments
Publication of the US Department of Health and Human Services/Centers for Disease Control and Prevention.